MeiraGTx Holdings (MGTX) FCF Margin (2019 - 2025)
MeiraGTx Holdings' (MGTX) quarterly FCF Margin came in at 61.51% in Q4 2025, up 17602.0% YoY from N/an in Q4 2024, and up 101.97% on a QoQ basis from 3128.05% in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) FCF Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 7 years of FCF Margin data on file, last reported at 61.51% in Q4 2025.
- Quarterly FCF Margin rose 17602.0% year-over-year to 61.51% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 49.76% (up 27913.0% YoY) and the FY2025 annual result came in at 61.66%, up 26723.0% from the prior year.
- FCF Margin grew to 61.51% in Q4 2025, from 3128.05% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 1155.81% in Q4 2022 to a low of 8189.72% in Q2 2024.
- A 5-year average of 1143.15% and a median of 388.58% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2024 — FCF Margin tumbled 722963 bps — and 2025, when it soared 696487 bps.
- Tracing MGTX's FCF Margin over 5 years: stood at 26.33% in 2021, then soared by 4489 bps to 1155.81% in 2022, then slumped by 169 bps to 801.03% in 2023, then jumped by 86 bps to 114.51% in 2024, then jumped by 154 bps to 61.51% in 2025.
- The last three FCF Margin figures came in at 61.51% (Q4 2025), 3128.05% (Q3 2025), and 1224.84% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 61.47% |
| Sep 30, 2025 | -3,130.49% |
| Jun 30, 2025 | -1,224.09% |
| Mar 31, 2025 | -2,000.93% |
| Dec 31, 2024 | -114.51% |
| Sep 30, 2024 | -236.04% |
| Jun 30, 2024 | -7,370.57% |
| Mar 31, 2024 | -5,512.05% |
| Dec 31, 2023 | -861.62% |
| Sep 30, 2023 | -548.27% |
| Jun 30, 2023 | -960.08% |
| Mar 31, 2023 | -1,379.63% |
| Dec 31, 2022 | 468.21% |
| Sep 30, 2022 | -638.23% |
| Jun 30, 2022 | -388.58% |
| Mar 31, 2022 | -368.51% |
| Dec 31, 2021 | -26.33% |
| Sep 30, 2021 | -418.65% |
| Jun 30, 2021 | -524.55% |
| Mar 31, 2021 | 99.76% |